Iofetamine (123I)

From WikiMD's WELLNESSPEDIA

A radiopharmaceutical used in brain imaging


Chemical structure of Iofetamine (123I)

Iofetamine (123I), also known as N-isopropyl-p-iodoamphetamine (IMP), is a radiopharmaceutical agent used primarily in nuclear medicine for brain imaging. It is a derivative of amphetamine and is labeled with the radioactive isotope iodine-123.

Chemical properties[edit]

Iofetamine is a lipophilic compound, which allows it to cross the blood-brain barrier efficiently. The presence of the iodine-123 isotope enables it to be detected using single-photon emission computed tomography (SPECT), a type of nuclear imaging technique.

Mechanism of action[edit]

Once administered, iofetamine (123I) is taken up by the brain tissue, where it is distributed in proportion to the regional cerebral blood flow. This property makes it useful for assessing cerebral perfusion and identifying areas of altered blood flow, which can be indicative of various neurological disorders.

Clinical applications[edit]

Iofetamine (123I) is used in the evaluation of several neurological conditions, including:

  • Stroke: To assess the extent of brain tissue affected by ischemia.
  • Epilepsy: To localize epileptogenic foci by identifying regions of altered perfusion.
  • Dementia: To evaluate patterns of cerebral blood flow that may be characteristic of different types of dementia.

Administration and imaging[edit]

The compound is typically administered intravenously. After administration, imaging is performed using a SPECT camera, which detects the gamma rays emitted by the decay of iodine-123. The resulting images provide information about the distribution of blood flow in the brain.

Safety and side effects[edit]

Iofetamine (123I) is generally well-tolerated. However, as with any radiopharmaceutical, there is a small risk of radiation exposure. The use of iodine-123, which has a relatively short half-life, helps to minimize this risk. Common side effects are rare but may include mild allergic reactions.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.